[1]
Vitfell-Rasmussen, J. et al. 2026. Cardiotoxicity, survival, and dexrazoxane use in patients with soft tissue sarcoma: a Danish population‑based cohort study. Acta Oncologica. 65, (Jul. 2026), 590–598. DOI:https://doi.org/10.2340/1651-226X.2026.45897.